Who
William Snider
Director
Company insider
Files Form 4 as: Director, Harvard Bioscience; Director and 10% owner, Telesis Bio; Other, Biomerica; Director, Alpha Innotech.
In numbers
- Trades disclosed
- 56
- Buys
- 9
- Sells
- 1
- Bought
- $443K
- Sold
- $8,068
- Companies
- 4
- Companies where not an officer
- 4
- First trade
- 13 Apr 2006
- Last trade
- 9 Jun 2026
- Last filed
- 11 Jun 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 9 Jun 2026filed 11 Jun 2026 | HBIO Harvard BioscienceLife-science tools | SEC FORM 4 Code A | —16,556 at $0.00 | filing |
| 9 Jun 2026filed 11 Jun 2026 | HBIO Harvard BioscienceLife-science tools | SEC FORM 4 Code A | —16,556 at $0.00 | filing |
| 17 Mar 2026filed 18 Mar 2026 | HBIO Harvard BioscienceLife-science tools | SEC FORM 4 Bought | $41K8,475 at $4.85 | filing |
| 17 Mar 2026filed 18 Mar 2026 | HBIO Harvard BioscienceLife-science tools | SEC FORM 4 Bought | $41K8,475 at $4.85 | filing |
| 16 Mar 2026filed 18 Mar 2026 | HBIO Harvard BioscienceLife-science tools | SEC FORM 4 Bought | $62K12,525 at $4.99 | filing |
| 16 Mar 2026filed 18 Mar 2026 | HBIO Harvard BioscienceLife-science tools | SEC FORM 4 Bought | $62K12,525 at $4.99 | filing |
| 17 Dec 2025filed 30 Dec 2025 | HBIO Harvard BioscienceLife-science tools | SEC FORM 4 Code A | —110,000 at $0.00 | filing |
| 5 Jun 2023filed 7 Jun 2023 | Telesis Biooption or derivative | SEC FORM 4 Code A | —20,000 | filing |
| 5 Jun 2023filed 7 Jun 2023 | Telesis Biooption or derivative | SEC FORM 4 Code A | —423,137 | filing |
| 5 Jun 2023filed 7 Jun 2023 | Telesis Biooption or derivative | SEC FORM 4 Code A | —846,274 | filing |
| 9 Jun 2022filed 13 Jun 2022 | Codex DNAoption or derivative | SEC FORM 4 Code A | —30,945 at $0.00 | filing |
| 9 Jun 2022filed 13 Jun 2022 | Codex DNA | SEC FORM 4 Code A | —20,630 at $0.00 | filing |
| 22 Jun 2021filed 23 Jun 2021 | Codex DNAoption or derivative | SEC FORM 4 Code C | —500,000 at $0.00 | filing |
| 22 Jun 2021filed 23 Jun 2021 | Codex DNAoption or derivative | SEC FORM 4 Code C | —541,677 at $0.00 | filing |
| 22 Jun 2021filed 23 Jun 2021 | Codex DNAoption or derivative | SEC FORM 4 Code C | —277,368 at $0.00 | filing |
| 22 Jun 2021filed 23 Jun 2021 | Codex DNA | SEC FORM 4 Code C | —1,319,045 at $0.00 | filing |
| 27 Sep 2010filed 27 Sep 2010 | BMRA BiomericaDiagnostics & Labs | SEC FORM 4 Code J | $200K500,000 at $0.40 | filing |
| 27 Sep 2010filed 27 Sep 2010 | BMRA BiomericaDiagnostics & Labs | SEC FORM 4 Code J | $200K500,000 at $0.40 | filing |
| 28 Oct 2009filed 29 Oct 2009 | Alpha Innotechoption or derivative | SEC FORM 4 Code D | —34,287 | filing |
| 28 Oct 2009filed 29 Oct 2009 | Alpha Innotechoption or derivative | SEC FORM 4 Code D | —10,000 | filing |
News
No headline names them, or the companies they trade most, lately.